Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 180 clinical trials
Tactile Low Vision Labeling of Ophthalmic Drops

The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch (UTMB) in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency …

  • 0 views
  • 16 Feb, 2024
  • 1 location
Mobility Protocol Adapted for Advanced Visually Impaired Subjects

They are proposing a new test adapted and carried out in real situations, in binocular and monocular vision, making it possible to finely assess locomotion especially for "very low vision" patients. This test will also ultimately make it possible to better evaluate the effectivements, that is to say to observe …

visual impairment
low vision
retinitis
cognitive disorders
amblyopia
  • 0 views
  • 16 Feb, 2024
  • 1 location
Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome (HBPCOVID02)

This study will enroll up to 80 subjects with Chronic Post COVID-19 Syndrome. Subjects will receive four intravenous injections of either allogeneic HB-adMSC's or a placebo over 10 weeks with two follow-up visits and an end of study visit at week 26.

  • 0 views
  • 10 Nov, 2022
  • 1 location
A Randomized Double-blind Study to Assess the Safety and Efficacy of EDP-305 in Subjects With Liver-biopsy Proven NASH

A randomized, double-blind study to assess the safety and efficacy of EDP-305 in subjects with liver-biopsy proven Non-Alcoholic Steatohepatitis (NASH)

HIV Infection
steatohepatitis
hcv infection
direct acting antivirals
steatosis
  • 0 views
  • 05 Aug, 2020
A Phase II Randomized, Double-blind, Placebo-controlled, Multi-center, Multi-dose Study to Evaluate Safety and Efficacy of ASC40 Tablets in Subjects With Moderate to Severe Acne Vulgaris.

This is a phase2, randomized, double-blind, multi-center, multi-dose and placebo parallel controlled design. The subjects in the study group were given double-blind drugs, and they were taken (orally) after dinner every day according to the requirements of clinical trial scheme.

  • 0 views
  • 10 Oct, 2022
  • 1 location
A Randomized, Double-blind, Positive-drug Parallel Controlled, Multicenter Phase III Trial of the Efficacy and Safety of S086 Tablets in Patients With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF)  

A randomized, double-blind, positive-drug parallel controlled, multicenter phase III trial of the efficacy and safety of S086 tablets in patients with chronic heart failure with reduced ejection fraction (HFrEF)

  • 0 views
  • 26 Sep, 2022
  • 5 locations
Evaluation of Safety Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants

This is a Phase 1, randomized, double-blind, third-party open (ie, participant-blind, investigator-blind and sponsor-open), placebo-controlled, dose escalating clinical study to evaluate the safety, tolerability, immunogenicity, PK and PD of PF-06480605 in Japanese healthy adult participants.

12 lead electrocardiogram
illicit drugs
coronary artery disease
herbal supplement
drug test
  • 0 views
  • 16 Feb, 2024
  • 1 location
Trial With the Treatment of Sertraline in Youth With Generalized Separation and/or Social Anxiety Disorders.

A Multicenter, acute, randomized, double-blind, placebo-controlled, flexible-dose trial with the treatment of sertraline.

sertraline
urine drug screen
nuvaring
anxiety
estrogen
  • 0 views
  • 16 Feb, 2024
  • 2 locations
Single-dose/Multiple-doses Incremental Intravenous Injection of SY-005 in Healthy Subjects

This is a single-dose/multiple-doses incremental, randomized, double-blind, parallel, placebo-controlled study on safety, tolerance and pharmacokinetics healthy subjects.

body mass index
  • 0 views
  • 16 Feb, 2024
  • 1 location
Study of LAU-7b for the Treatment of COVID-19 Disease in Adults

A randomized, double-blind, placebo-controlled Phase 2 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.

  • 0 views
  • 05 Aug, 2020